Neuropsychopharmacology
- Antidepressants enter cells, organelles, and membranes3 years ago
- Correction: Digital and precision clinical trials: innovations for testing mental health medications, devices, and psychosocial treatments3 years ago
- Basolateral amygdala neuropeptide Y system modulates binge ethanol consumption3 years ago
- Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex3 years ago
- Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala3 years ago
- C-reactive protein moderates associations between racial discrimination and ventromedial prefrontal cortex activation during attention to threat in Black American women3 years ago
- In memoriam: Eugene S Paykel, MD, FRCP, FRCPsych, FMedSci3 years ago
Journal of Psychopharmacology
- Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia6 years ago
- Effects of caffeine on ethanol-elicited place preference, place aversion and ERK phosphorylation in CD-1 mice6 years ago
- Dissociable contributions of mediodorsal and anterior thalamic nuclei in visual attentional performance: A comparison using nicotinic and muscarinic cholinergic receptor antagonists6 years ago
- Effect of serotonin transporter genotype on carbon dioxide-induced fear-related behavior in mice6 years ago
- The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling6 years ago
- Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment6 years ago
- Histamine H3 receptor gene variants associated with drug abuse in patients with cocaine use disorder6 years ago
European Neuropsychopharmacology
- Drug development in ASD, an ISCTM-ECNP joint adventure5 years ago
- GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site5 years ago
- Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis5 years ago
- Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS)5 years ago
- Comorbidities and behavioral issues5 years ago
- Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk5 years ago
- Commentary on: Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness, and neurocognitive performance in healthy volunteers5 years ago